These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968 [TBL] [Abstract][Full Text] [Related]
3. Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation. Nakagome K; Nagata M Front Immunol; 2022; 13():865973. PubMed ID: 35795686 [TBL] [Abstract][Full Text] [Related]
4. TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. Parsons KS; Hsu AC; Wark PA Clin Exp Allergy; 2014 Jan; 44(1):91-101. PubMed ID: 24131248 [TBL] [Abstract][Full Text] [Related]
5. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737 [TBL] [Abstract][Full Text] [Related]
6. Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. Zhu J; Message SD; Mallia P; Kebadze T; Contoli M; Ward CK; Barnathan ES; Mascelli MA; Kon OM; Papi A; Stanciu LA; Edwards MR; Jeffery PK; Johnston SL J Allergy Clin Immunol; 2019 Jan; 143(1):114-125.e4. PubMed ID: 29698627 [TBL] [Abstract][Full Text] [Related]